Literature DB >> 24251018

Past, present, and future of minimal access cardiac surgery.

Shahzad G Raja1, Mohamed Amrani.   

Abstract

Year:  2013        PMID： 24251018      PMCID： PMC3831842          DOI： 10.3978/j.issn.2072-1439.2013.07.23

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  5 in total

1.  Port-access minimally invasive CABG: techniques and results.

Authors:  G H Ribakove; E A Grossi; B M Steinberg; P Ursomanno; S B Colvin; A C Galloway
Journal:  J Card Surg       Date:  2000 Jul-Aug       Impact factor: 1.620

Review 2.  Review of a 13-year single-center experience with minimally invasive direct coronary artery bypass as the primary surgical treatment of coronary artery disease.

Authors:  David M Holzhey; Jan P Cornely; Ardawan J Rastan; Piroze Davierwala; Friedrich W Mohr
Journal:  Heart Surg Forum       Date:  2012-04       Impact factor: 0.676

3.  Mini-sternotomy aortic valve replacement: is it safe and effective? Comparison with standard techniques.

Authors:  Balakrishnan Mahesh; Manoraj Navaratnarajah; Kwabena Mensah; Charles Ilsley; Mohamed Amrani
Journal:  J Heart Valve Dis       Date:  2011-11

4.  Five hundred cases of robotic totally endoscopic coronary artery bypass grafting: predictors of success and safety.

Authors:  Nikolaos Bonaros; Thomas Schachner; Eric Lehr; Markus Kofler; Dominik Wiedemann; Patricia Hong; Brody Wehman; David Zimrin; Mark K Vesely; Guy Friedrich; Johannes Bonatti
Journal:  Ann Thorac Surg       Date:  2013-01-10       Impact factor: 4.330

5.  Mitral valve surgery: comparison of outcomes in matched sternotomy and port access groups.

Authors:  William H Ryan; William T Brinkman; Todd M Dewey; Michael J Mack; Syma L Prince; Morley A Herbert
Journal:  J Heart Valve Dis       Date:  2010-01
  5 in total
  1 in total

Review 1.  Videoscope-assisted cardiac surgery.

Authors:  Kuan-Ming Chiu; Robert Jeen-Chen Chen
Journal:  J Thorac Dis       Date:  2014-01       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.